Nalaganje...

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer

KRAS is the most frequently mutated oncogene in non‐small cell lung cancer (NSCLC). However, the prognostic role of KRAS mutation status in NSCLC still remains controversial. We hypothesize that the expression changes of genes affected by KRAS mutation status will have the most prominent effect and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Cancer
Main Authors: Nagy, Ádám, Pongor, Lőrinc Sándor, Szabó, András, Santarpia, Mariacarmela, Győrffy, Balázs
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299512/
https://ncbi.nlm.nih.gov/pubmed/27859136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30509
Oznake: Označite
Brez oznak, prvi označite!